市場調查報告書
商品編碼
1603759
農業基因工程的全球市場預測(~2030 年):按技術、應用、最終用戶和區域進行分析Genetic Engineering in Agriculture Market Forecasts to 2030 - Global Analysis By Technique, Application, End User and by Geography |
根據Stratistics MRC預測,2024年全球基因工程在農業市場規模將達10.9億美元,預測期內複合年成長率為8.5%,預計2030年將達到17.7億美元。農業基因工程涉及修改農作物和牲畜的 DNA,以增強產量、抗蟲性、耐旱性和營養等特定性狀。生物技術的發展使科學家能夠將有利的基因直接引入植物和動物中,從而實現傳統育種難以實現的精確改良。此外,抗蟲玉米和耐除草劑大豆是基因工程(GE)作物的兩個例子,它們在世界範圍內得到了廣泛接受,因為它們可以在減少化學投入的同時提高產量。
根據聯合國糧食及農業組織 (FAO) 統計,2022 年全球基因改造 (GE)作物面積約 1.9 億公頃。
引進基改作物(GMO)
由於其眾多的好處,基因改造作物的採用率正在穩步上升。基因改造作物對農民很有吸引力,因為它們通常需要較少的投入,例如肥料和水,並且對病蟲害具有更強的抵抗力。它不僅提高了農民的盈利,而且還透過減少化學品的使用量來減少對環境的影響。基因改造作物現在在法律規範較為寬鬆的地區(例如北美)的農業實踐中很常見。此外,隨著消費者越來越意識到基改作物的好處,例如增加營養價值和減少食品廢棄物,公眾輿論也逐漸轉變,這將鼓勵更廣泛的採用。
社會和道德問題
基因工程提出了關於「神化」自然和為了人類的利益而改變生物體是否適當的倫理問題。基因改造因損害自然過程並可能產生意想不到的後果而受到批評。大型生技公司對種子專利的壟斷進一步引發了社會擔憂,因為這可能會限制農民以後保存和使用收穫種子的能力。此外,這種方法可能導致小農依賴種子公司進行年度採購,引發人們對種子取得和經濟公平的擔憂。
作物新品種開發
基因工程市場充滿了創造適合特定消費者偏好和當地要求的創新作物品種的機會。例如,可以對作物進行改良,使其具有更好的味道和質地,或具有更長的保存期限,從而提高適銷性並減少整個供應鏈中的食品廢棄物。也有潛力開拓滿足專業市場和新消費趨勢的特種作物,例如無麩質和有機產品。
公共衛生問題
對基因改造食品的接受仍然受到公共衛生問題的嚴重威脅。儘管科學界對基因改造食品的安全性已達成共識,但一些消費者仍擔心食用基因改造食品可能產生毒性和過敏。有關不良健康影響的報告要求對基因改造產品進行更徹底的測試和標籤。此外,相關人員很難有效傳達基因改造的好處。這是因為假訊息宣傳活動和不利的媒體報導加劇了這些恐懼。
COVID-19 大流行擾亂了供應鏈和勞動力供應、降低了作物產量並導致研發延誤,對農業基因工程市場產生了重大影響。進出口限制限制了獲得關鍵生物技術工具和資源的機會,而封鎖造成了農業勞動力短缺,並擾亂了種植和收割作業。此外,這場大流行提高了人們對糧食安全問題的認知,並增加了對生物技術解決方案的興趣。然而,隨著該行業尋求從這些挫折中恢復過來,農民的經濟負擔和農業創新投資的減少可能會對市場擴張構成長期障礙。
DNA 和 RNA 定序領域預計在預測期內規模最大
預計最大佔有率出現在 DNA/RNA 序列片段中。這部分至關重要,因為它透過精確的遺傳分析和修改在提高農業生產力方面發揮關鍵作用。透過 DNA 和 RNA定序技術鑑定與所需性狀相關的遺傳標記,有助於開發具有更高產量、抗病性和營養價值的基因改造作物。此外,作物改良越來越依賴基因工程技術和分子標記,這不僅有利於育種,而且有助於了解植物性因組,這也強調了這一領域的重要性。
水果和蔬菜領域預計在預測期內複合年成長率最高
水果和蔬菜領域預計將呈現最高的複合年成長率。這種成長主要是由於對健康和食品的需求不斷增加食品消費者對水果和蔬菜營養價值的認知不斷提高。隨著越來越多的消費者更加重視健康的飲食習慣,迫切需要開發更美味、更長保存期限、更有營養的改良品種。此外,支持該市場成長的是都市區園藝和當地食品生產的日益普及,基因改造蔬菜和水果成為尋求健康、新鮮農產品的消費者的特色,因為它可以滿足您的需求。
北美在農業基因工程方面佔據最大的市場佔有率。這項優勢的主要原因是美國和加拿大等國家擁有發達的農業基礎設施、強大的研發能力以及對基因改造生物(GMO)的支持性法規結構。對基因工程技術的大規模投資提高了作物產量、提高了害蟲抗性並減少了對化學投入的依賴,使北美處於農業生物技術採用的前沿。此外,該地區成熟的生物技術部門以及農民和消費者對基因改造作物的高接受度進一步加強了該地區的市場主導地位。
農業基因工程市場預計將以亞太地區最高的複合年成長率成長。人口的快速成長、糧食需求的增加以及擴大使用尖端分子生物學和遺傳學技術來提高作物產量和生產力是推動這一成長的因素。中國和印度等國家處於領先地位,它們正在大力投資生物技術研發,以解決土壤劣化和氣候變遷等農業問題。此外,重要生物技術公司的存在以及政府對農業創新的持續支持進一步支持了該領域的市場成長。
According to Stratistics MRC, the Global Genetic Engineering in Agriculture Market is accounted for $1.09 billion in 2024 and is expected to reach $1.77 billion by 2030 growing at a CAGR of 8.5% during the forecast period. Genetic engineering in agriculture involves modifying the DNA of crops and livestock to enhance specific traits, such as yield, pest resistance, drought tolerance, and nutritional content. Scientists can now directly introduce advantageous genes into plants or animals thanks to this biotechnological development, making precise improvements that would be difficult to accomplish through conventional breeding. Moreover, insect-resistant corn and herbicide-tolerant soybeans are two examples of genetically engineered (GE) crops that have gained widespread acceptance around the world because of their capacity to boost output while lowering the demand for chemical inputs, thereby encouraging more sustainable farming methods.
According to the Food and Agriculture Organization (FAO), genetically engineered (GE) crops covered approximately 190 million hectares globally in 2022.
Genetically modified organism (GMO) adoption
The adoption rate of GMOs has been steadily increasing due to their numerous benefits. Genetically modified crops appeal to farmers because they frequently require fewer inputs, like fertilizer and water, while offering greater resistance to pests and diseases. In addition to making farmers more profitable, this also helps to lessen the impact on the environment by using fewer chemicals. GMOs are now commonplace in agricultural practices in areas with more benevolent regulatory frameworks, such as North America. Furthermore, there is a slow change in public opinion that encourages broader adoption as consumer awareness of the advantages of GMOs, such as increased nutritional value and decreased food waste, increases.
Social and ethical concerns
Genetic engineering raises ethical questions about "playing God" with nature and the propriety of modifying living things for the sake of humanity. Genetic modification is criticized for undermining natural processes and potentially having unintended consequences. Large Biotech Company's monopolization of seed patents raises additional societal concerns because it may restrict farmer's ability to save seeds from their harvests for later use. Moreover, this approach may lead to smallholder farmers becoming dependent on seed companies for yearly purchases, which raises concerns about access and economic equity.
Development of novel crop varieties
The market for genetic engineering offers a wealth of chances to create innovative crop varieties suited to particular consumer preferences or regional requirements. For instance, it is possible to engineer crops to have better taste and texture or longer shelf lives, which will increase their marketability and decrease food waste across the supply chain. Additionally, there is also the possibility of developing specialty crops that serve specialized markets or new consumer trends, like gluten-free or organic products.
Issues with public health
Genetically modified food acceptance is still seriously threatened by public health concerns. Notwithstanding the scientific consensus regarding the safety of genetically modified foods, some consumers are concerned about the possibility of toxicity or allergies when consuming GMOs. Reports of negative health effects have prompted demands for more thorough testing and labeling of genetically modified products. Furthermore, it is also difficult for stakeholders to effectively convey the advantages of genetic engineering because of disinformation campaigns and unfavorable media representations that heighten these anxieties.
The COVID-19 pandemic had a major effect on the market for genetic engineering in agriculture by interfering with supply chains and labor availability, which decreased crop yields and caused delays in R&D. While import and export restrictions restricted access to vital biotechnology tools and resources, lockdowns caused a shortage of agricultural workers, which hampered planting and harvesting operations. Moreover, the pandemic raised awareness of food security concerns and sparked a surge in interest in biotechnology solutions; nevertheless, the financial burden on farmers and decreased investment in agricultural innovation may present long-term obstacles to market expansion as the sector attempts to bounce back from these setbacks.
The DNA & RNA Sequencing segment is expected to be the largest during the forecast period
The largest share is expected to be held by the DNA & RNA sequencing segment. Because it plays a crucial part in increasing agricultural productivity through accurate genetic analysis and modification, this segment is essential. The development of genetically modified crops with increased yields, disease resistance, and nutritional value is made easier by the identification of genetic markers linked to desired traits made possible by DNA and RNA sequencing technologies. Additionally, the importance of the segment is highlighted by the growing reliance on transgenic technology and molecular markers for crop improvement, which not only facilitates breeding but also helps understand plant genomes.
The Fruits & Vegetables segment is expected to have the highest CAGR during the forecast period
The fruits and vegetables segment is projected to exhibit the highest CAGR. This growth is mostly due to rising demand for health and wellness foods as well as growing consumer awareness of the nutritional advantages of fruits and vegetables. It is imperative to develop improved varieties with better taste, longer shelf life, and higher nutritional value as more consumers place a higher priority on eating a healthy diet. Furthermore, supporting the growth of this market is the growing popularity of urban gardening and local food production, as genetically modified fruits and vegetables can satisfy the particular needs of consumers looking for wholesome, fresh produce.
The North American region holds the largest market share for genetic engineering in agriculture. The main reasons for this dominance are the developed agricultural infrastructure, robust R&D capacities, and supportive regulatory framework for genetically modified organisms (GMOs) in nations such as the US and Canada. With large investments in genetic engineering technologies that increase crop yields, improve pest resistance, and lessen dependency on chemical inputs, North America has been at the forefront of the adoption of agricultural biotechnology. Moreover, the region's dominant position in the market is further cemented by its well-established biotech sector and the high rate of farmer and consumer acceptance of GM crops.
The market for genetic engineering in agriculture is anticipated to grow at the highest CAGR in the Asia-Pacific region. Rapid population growth, which raises food demand, and the growing use of cutting-edge molecular biology and genetics technologies to increase crop yield and productivity are some of the factors contributing to this growth. Leading the way in this trend are nations like China and India, which have made significant investments in biotechnology research and development to tackle issues in agriculture like soil degradation and climate variability. Additionally, the market's growth in this area is further supported by the existence of significant biotechnology firms and continuous government assistance for agricultural innovation.
Key players in the market
Some of the key players in Genetic Engineering in Agriculture market include Agilent Technologies, Illumina, Inc., Eurofins Scientific, Qiagen N.V., Neogen Corporation, Traitgenetics GmbH, Keygene, Synthego Corporation, Oxford Nanopore Technologies, Novogene Corporation, GenScript, Trace Genomics, Intellia Therapeutics and NRgene.
In October 2024, Eurofins Scientific, a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular clinical diagnostics testing and in-vitro diagnostic products, has reached an agreement with SYNLAB to acquire its clinical diagnostics operations in Spain. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in 2025.
In August 2024, Illumina Inc, a major biotech firm in DNA sequencing and array-based technologies, on Friday announced the setting up of a Global Capability Center in Bengaluru. The centre would be an investment to expand its technology workforce in support of a global customer base.
In July 2024, Agilent Technologies Inc. has signed a definitive agreement to acquire BIOVECTRA, a specialized contract development and manufacturing organization (CDMO), for $925 million. Based in Canada, BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.